Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PC-SPES: herbal formulation for prostate cancer.

Leonard S Marks1, Robert S DiPaola, Peter Nelson

  • 1Urological Sciences Research Foundation, Culver City, California 90232, USA.

Urology
|September 28, 2002
PubMed
Summary

PC-SPES, an herbal supplement, shows promise in treating prostate cancer (CaP) by inducing a castrate-like state. It significantly reduces prostate-specific antigen levels in most patients, including those with androgen-independent CaP.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First, Do No Harm.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Frontiers in Systemic Therapy for Unresectable or Metastatic Adrenocortical Carcinoma: Harnessing Novel Therapeutic Approaches.

Clinical Medicine Insights. Oncology·2025
Same author

Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes Czernin.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024
Same author

[<sup>89</sup>Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.

The Lancet. Oncology·2024
Same author

Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2024
Same author

ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review.

JCO precision oncology·2024

Area of Science:

  • Phytochemistry
  • Oncology
  • Pharmacology

Background:

  • PC-SPES is an eight-herb formulation available to consumers.
  • It demonstrates potential efficacy in prostate cancer (CaP) treatment.
  • Its use is widespread among patients seeking non-prescription options.

Purpose of the Study:

  • To evaluate the efficacy of PC-SPES in prostate cancer treatment.
  • To understand its effects on prostate-specific antigen (PSA) levels.
  • To explore its potential mechanisms of action and side effects.

Main Methods:

  • Clinical observation of patients using PC-SPES.
  • Monitoring of PSA levels and androgen-dependent/independent CaP status.
  • Analysis of reported side effects and potential biological mechanisms.

Related Experiment Videos

Main Results:

  • PC-SPES induces a castrate status, significantly reducing PSA levels in most CaP patients.
  • Efficacy observed in both androgen-dependent and androgen-independent CaP.
  • Potential mechanisms include androgen receptor downregulation and apoptosis induction.

Conclusions:

  • PC-SPES exhibits promising efficacy, potentially exceeding androgen ablation alone.
  • Common side effects include hormonal changes; rare thromboembolic events and bleeding diatheses reported.
  • Further research, particularly in androgen-independent CaP, is warranted.